# Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

> **NCT01828554** · NA · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 8 (actual)

## Conditions studied

- Obesity
- Neoplasms

## Interventions

- **DRUG:** Xeloda

## Key facts

- **NCT ID:** NCT01828554
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01828554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01828554, "Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01828554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*